DRKS00005294招募中不适用
ROUTE registry
IPPMed GmbH0 个研究点目标入组 200 人开始时间: 2013年11月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Intended transaortic (Tao) TAVI using Edwards SAPIEN XT Transcatheter Heart Valve with the Ascendra+ Delivery-System
- •- Compliance with the indications according to the Instructions for Use (Appendix 12.1)
- •- Written informed consent
排除标准
- •- Presence of contraindications as to the Instructions for Use
- •- TAo with concomitant procedure (e.g. Tao + CABG)
- •- Participation in the SOURCE XT registry
- •Data collection and follow-up
- •Patient data are collected at valve implantation
研究者
相似试验
招募中
不适用
TARGET registryK50K51K52.3Indeterminate colitisCrohn disease [regional enteritis]Ulcerative colitisDRKS00015785Kompetenznetz Darmerkrankungen4,400
进行中（未招募）
不适用
TARGIT R: TARGeted Intraoperative radioTherapy (TARGIT) Registry databaseCancerISRCTN91179875niversity College London (UK)
进行中（未招募）
不适用
未命名试验EUCTR2015-000142-29-FRCHU CLERMONT-FERRAND
尚未招募
1 期
Clinical observation of modified Buzhong Yiqi decoction combined with PKEP in the treatment of BPH with DBenign Prostatic HyperplasiaITMCTR2200006857Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine
已完成
不适用
Reveal LINQ Registrynexplained syncope Cryptogenic SrokeJPRN-UMIN000023158Medtronic Japana Co., Ltd1,614